Related Experiment Video
Updated: Mar 24, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-mediated MAPK signaling promotes isoliensinine-induced apoptosis in oral squamous cell carcinoma via the
Zi-Wei Cai1,2, Wei Zhao1, Yu-Ping Gong3
1School of Basic Medicine, Chengdu Medical College Chengdu 610500, Sichuan, China.
Abstract:
Oral squamous cell carcinoma (OSCC) is a common malignancy. Isoliensinine, a bisbenzylisoquinoline alkaloid from Nelumbo nucifera Gaertn, exhibits diverse biological activities, but its microRNA-mediated regulation of the MAPK pathway in anti-OSCC remains unreported. Therefore, this study took OSCC cell lines HSC-3 and HSC-4 as research objects to explore the biological activity and the molecular mechanism of isoliensinine on OSCC. The CCK-8 results revealed that isoliensinine inhibited the proliferation of HSC-3 and HSC-4 cells in a time and drug concentration-dependent manner. Analysis of mRNA and small RNA sequencing revealed that isoliensinine induced significant differences in the expression of 1878 genes and 77 microRNAs (miRNAs) in HSC-3 cells. The GO and KEGG analyses of these differentially expressed genes and miRNAs unveiled their potential role in modulating MAPK signaling. Flow cytometry analysis demonstrated that isoliensinine significantly increased reactive oxygen species (ROS) levels, reduced mitochondrial membrane potential (MMP), induced apoptosis, and caused G2 phase arrest in HSC-3 and HSC-4 cells. Western blot results indicated that isoliensinine upregulated the expression of p-p38, p-SAPK/JNK, p-cdc2, p-cdc25C, Bax, cleaved caspase-9/-3, and cleaved PARP, and downregulated the expression of p-ERK1/2, Bcl-2, and Cyclin B1 in HSC-3 and HSC-4 cells. The results demonstrate that isoliensinine induces apoptosis in OSCC cells via ROS-mediated mitochondrial pathways and cell cycle arrest, a process associated with MAPK signaling pathway activation. Transcriptome analysis further revealed that isoliensinine modulates multiple miRNAs that target the MAPK pathway, suggesting that miRNA regulation may mediate its activation of MAPK signaling.
Insights
Isoliensinine, a natural compound, inhibits oral cancer cell growth by inducing apoptosis and cell cycle arrest. It also modulates microRNAs targeting the MAPK pathway, offering a potential new treatment for oral squamous cell carcinoma (OSCC).
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Oral squamous cell carcinoma (OSCC) is a prevalent cancer with limited treatment options.
- Isoliensinine, a bisbenzylisoquinoline alkaloid from Nelumbo nucifera, shows biological activity but its anti-OSCC mechanisms, particularly microRNA (miRNA)-mediated MAPK pathway regulation, are unexplored.
Purpose of the Study:
- To investigate the anti-OSCC biological activity of isoliensinine.
- To elucidate the molecular mechanisms underlying isoliensinine's effects on OSCC, focusing on miRNA and MAPK pathway involvement.
Main Methods:
- Cell viability assays (CCK-8) were performed on OSCC cell lines (HSC-3, HSC-4).
- mRNA and small RNA sequencing analyzed gene and miRNA expression changes.
- Gene Ontology (GO) and KEGG pathway analyses identified affected pathways.
- Flow cytometry assessed reactive oxygen species (ROS), mitochondrial membrane potential (MMP), apoptosis, and cell cycle.
- Western blotting examined key protein expressions related to apoptosis and cell cycle.
Main Results:
- Isoliensinine inhibited OSCC cell proliferation in a dose- and time-dependent manner.
- Significant alterations in 1878 genes and 77 miRNAs were observed, primarily impacting the MAPK signaling pathway.
- Isoliensinine induced apoptosis via ROS-mediated mitochondrial pathways and G2 phase cell cycle arrest.
- Upregulation of pro-apoptotic proteins (Bax, cleaved caspase-9/-3, cleaved PARP) and MAPK pathway components (p-p38, p-SAPK/JNK) was noted.
- Downregulation of anti-apoptotic protein (Bcl-2) and cell cycle regulators (p-ERK1/2, Cyclin B1) was observed.
Conclusions:
- Isoliensinine exhibits significant anti-OSCC activity by inducing apoptosis and cell cycle arrest.
- The anti-cancer effects are linked to ROS generation, mitochondrial dysfunction, and MAPK pathway activation.
- Isoliensinine modulates specific miRNAs that target the MAPK pathway, suggesting a novel miRNA-dependent regulatory mechanism in its anti-OSCC action.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway